Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Dexanabinol (ETS2101)
print preview
bookmark
share with colleague
General Information
Company
e-Therapeutics plc
Description
Small molecule chemotherapeutic synthetic cannabinoid
Molecular Target
Not available
Mechanism of Action
Cytotoxic agent
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy